CA-KKR
1.6.2021 08:32:08 CEST | Business Wire | Press release
Silver Lake, a global leader in technology investing, today announced that it has agreed to make a minority investment in Exact, a leading provider of business and accounting software in the Benelux region. This investment will be in partnership with the management team, led by CEO Paul Ramakers, and the company’s existing investor, KKR, which will remain the majority shareholder.
Founded in 1984 and headquartered in Delft, the Netherlands, Exact's innovative software solutions today help more than 9,900 accountants manage the finances of small and mid-size enterprises and provide over 550,000 small businesses with high value-add solutions in the cloud. Exact's mid-market enterprise resource planning ("ERP") solutions are also used by over 16,000 mid-sized firms, with a choice of cloud or on-premise deployment. The company's integrated software suite includes Financial Management, Logistics, CRM, HR, and Payroll. Since the acquisition by KKR in 2019, Exact has experienced rapid growth and has expanded its market leadership.
Jean-Pierre Saad, Partner and Head of EMEA Technology at KKR, Daniel Knottenbelt, Partner and Head of Benelux at KKR and Tomas Kubica, Director Technology Private Equity at KKR, said: “We are delighted to welcome Silver Lake as an investor alongside us in Exact, one of the leading European SaaS businesses. We have seen tremendous growth in recent years under the leadership of Paul Ramakers and the entire team. The company continues to be a leading platform to provide accounting and business software in the Benelux region and beyond, notably with its flagship SaaS product Exact Online, and we believe that Silver Lake’s relevant experience will further contribute to the growth and ambitious expansion strategy of Exact.”
Christian Lucas, Co-Head of Silver Lake EMEA, said: “Exact fits very naturally into Silver Lake’s strategy of investing in high growth, innovative and world leading technology companies. Paul and the Exact team have achieved a strong growth trajectory, and we have been impressed by the high quality of their best-in-class SaaS solutions. We are excited to partner with the management team and KKR, one of the world’s leading technology and software investors, to contribute to the next stage of Exact’s development towards achieving its full long-term potential.”
Paul Ramakers, CEO of Exact, said: “We are proud of what Exact has already achieved with the strong support of the KKR team. Together, with our outstanding team and business partners, we have built a successful business, with a strong track record of supporting both accountancy firms and small and mid-size businesses in Benelux. As we enter the next exciting stage of our growth story, we look forward to leveraging Silver Lake’s software domain expertise and extensive industry network.”
The transaction is anticipated to close in the third quarter subject to customary conditions and regulatory approvals. Further terms of the investment are not being disclosed at this time.
About KKR
KKR is a leading global investment firm that offers alternative asset management and capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of The Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at kkr.com and on Twitter @KKR_Co.
About Silver Lake
Silver Lake is a leading global technology investment firm, with more than $83 billion in combined assets under management and committed capital and a team of professionals based in North America, Europe, and Asia. Silver Lake's portfolio companies collectively generate more than $196 billion of revenue annually and employ more than 448,000 people globally. For more information about Silver Lake and its portfolio, please visit Silver Lake’s website at silverlake.com.
About Exact
Founded in 1984 and headquartered in Delft, the Netherlands, Exact's innovative solutions today help over 9,900 accountants manage the finances of over 550,000 small businesses in the cloud. Exact's mid-market enterprise resource planning ("ERP") solutions are also used by over 16,000 mid-sized firms, with a choice of cloud or on-premise deployment. The company's integrated software suite includes Financial Management, Logistics, CRM, HR, and Payroll. Exact employs 1,850 people. For more information on Exact, please visit exact.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210531005304/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 14:30:00 CET | Press release
Investment lead by OTB Ventures and Alpha Intelligence CapitalWaiv develops AI-powered precision testing to better identify and stratify patients in the clinic and in clinical trials, transforming patient careWaiv extends Owkin’s strategy of real-world validation for its AI Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and colla
RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 14:30:00 CET | Press release
Helps MedTech Companies Navigate MDR, IVDR, and AI-Enabled Device Development RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that h
Cryptio Raises $45m Series B as Digital Assets Move Into Regulated Financial Markets12.3.2026 14:06:00 CET | Press release
The system of record for tokenized finance – ERP infrastructure for institutions operating in digital assets Cryptio, a leader in financial data transformation and enterprise resource planning (ERP) applications for regulated digital assets, announced today a $45 million Series B funding round co-led by BlackFin Capital Partners and Sentinel Global, with participation from 1kx, Alven, BlueYard Capital and Ledger Cathay Capital. Banks, exchanges, asset managers, including Société Générale’s SG Forge, Circle, Gemini, and Securitize rely on Cryptio to ensure financial integrity across their digital assets businesses. Existing ERP systems fall short for digital assets Traditional ERP and accounting systems were not designed for blockchain-native assets, real-time reporting, or modern custody frameworks. As regulated financial institutions expand into stablecoins, tokenized securities and other on-chain instruments, these limitations create material operational and reporting challenges. Cry
HyperLight Introduces 145 GHz Reference Modulators to Enable 448Gbps per Lane Datacom and 260GBaud Telecom Development12.3.2026 14:03:00 CET | Press release
HyperLight Corporation, creator of the TFLN Chiplet™ platform, today announced the release of its 145 GHz Packaged Intensity Modulator (IM), expanding the company‘s high-speed modulator portfolio. The new device is designed for ultra-wide modulation bandwidth, high signal fidelity, and stable operation control, enabling 448 Gbps per lane intensity-modulated-direct-detection (IMDD), 260 GBaud coherent links, and broadband RF photonics systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312319685/en/ Fig. 1: HyperLight’s 145 GHz intensity modulator for 448Gbps per lane IMDD and 260GBaud coherent applications, with operational electro-optical bandwidth >145GHz, stable bias control, 0.8 mm-connector; available in O-, C-, and L-bands. As symbol rates and analog bandwidth requirements continue to rise across data center interconnects, AI-driven photonics infrastructure, and laboratory test environments, system architects in
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences12.3.2026 14:00:00 CET | Press release
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Enodia has acquired Kezar’s assets from its Sec61-based discovery and development program. The acquisition enables Enodia to advance its understanding of Sec61 selectivity mechanisms, expanding biological and translational insights for faster progression toward key clinical milestones. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312627573/en/ Under the terms of the purchase agreement between Enodia and Kezar, Kezar w
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom